Medinex

What Medinex does

Medinex Laboratories Private Limited is an Indian pharmaceutical manufacturer founded in 1972 by Chairman N N Thakkar and headquartered in Mumbai, with manufacturing operations at a state-of-the-art facility in Ukharla, Bhavnagar (Gujarat) commissioned in November 2006. Until 2006 the company manufactured finished formulations; it subsequently pivoted to specialize in the manufacture of niche Active Pharmaceutical Ingredients (APIs) and specialty chemicals, particularly adrenaline-based compounds such as Adrenaline (Epinephrine), Noradrenaline (Norepinephrine) and Isoprenaline, alongside other cardiovascular, diuretic, antiemetic, muscle relaxant and amino-acid APIs. The company reports having developed Carbazochrome JP in 1982 — described as the first API developed in India — and maintains an in-house R&D facility recognized by India's Department of Science and Technology.

The manufacturing platform comprises four separate production blocks with Class 100,000 air circulation and pressure differentials to prevent cross-contamination, supported by a Quality Control laboratory equipped with HPLC, GC-HS, UV spectrophotometer and FTIR instruments, plus a captive effluent treatment plant and a captive solar power plant. Products are released under multi-pharmacopoeial grade specifications (IP, BP, EP, USP, JP) and are backed by WHO-GMP (2017) and ISO 9001:2015 certifications, CEP certificates from EDQM for Adrenaline Tartrate EP and Noradrenaline Tartrate EP, EU Written Confirmations for seven APIs, and COFEPRIS approval from Mexico. Drug Master File (DMF/CTD) submissions have been made in 13 countries across Europe, Asia, Africa and Latin America. A pipeline of four 'launching shortly' APIs and three R&D-stage molecules (Dipivefrine HCl, Hydralazine HCl, Isoprenaline Sulphate) is in place.

The business model is B2B direct sales of APIs and specialty chemicals to pharmaceutical formulators, both domestically in India (via [email protected]) and through dedicated export sales ([email protected]) to regulated and semi-regulated international markets. Pricing is quote-based and not publicly disclosed. Customer acquisition is driven by participation in international pharmaceutical exhibitions (COEX Seoul, IFEMA Madrid), the company website inquiry portal, and direct enterprise relationships. Medinex is a privately held, founder-controlled company with no disclosed external institutional investment, parent entity, or funding history in the source data.

Name

Medinex

Legal name

Medinex Laboratories

Website

https://medinex.in

Company type

Private

Founded year

1972

Operating status

Operating

Headcount range

11–50 employees

Short description

Medinex Laboratories is an Indian cGMP-certified manufacturer specializing in niche adrenaline-based Active Pharmaceutical Ingredients (Adrenaline, Noradrenaline, Isoprenaline) and related specialty chemicals, supplying global pharmaceutical formulators across 13+ countries from its Bhavnagar, Gujarat facility.

Ownership category

akta.pro rank

Product category

Pharmaceutical API Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Controlled Substances / DEA-Scheduled API Manufacturing (HLAGAHAD)

akta.pro secondary industry

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

Keywords

• Pharmaceutical API manufacturing
• Active pharmaceutical ingredients
• Specialty chemicals manufacturing
• Niche drug substances
• GMP-certified manufacturing

Headquarters

HQ city

Jogeshwari

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Supply Chain, Personnel, Infrastructure, Marketing or Sales, Others

Revenue model

1. API Manufacturing and Sales: Manufactures and sells Active Pharmaceutical Ingredients (APIs) and specialty chemicals to pharmaceutical companies globally. Products include adrenaline-based APIs, cardiovascular drugs, muscle relaxants, antiemetics, diuretics, and amino acids. Revenue generated through direct B2B sales to pharmaceutical manufacturers.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Medinex manufactures and sells niche Active Pharmaceutical Ingredients (APIs) — particularly adrenaline-based APIs such as Adrenaline (Epinephrine), Noradrenaline (Norepinephrine), and Isoprenaline — and a line of specialty chemicals, all produced in a cGMP-compliant facility at Bhavnagar, Gujarat. Products are supplied to global pharmaceutical formulation manufacturers in multiple pharmacopoeial grades (IP, BP, EP, USP, JP) with full DMF/CTD documentation and CEP certificates for key molecules.

Product overview

Medinex is a pharmaceutical manufacturer specializing in niche Active Pharmaceutical Ingredients (APIs) and Speciality Chemicals. The company operates two product lines: (1) APIs including Adrenaline-based products (Adrenaline Bitartrate, Adrenaline Tartrate, Epinephrine Bitartrate), Noradrenaline-based products (Noradrenaline Bitartrate, Noradrenaline Tartrate, Norepinephrine Bitartrate), and other pharmaceutical compounds such as Aripiprazole, Carbazochrome, Chlorzoxazone, Hydrochlorothiazide, and Dimenhydrinate; and (2) Speciality Chemicals including Acetone Semicarbazone, Hydrazine Sulphate, and Thiosemicarbazide. Medinex also maintains a pipeline of upcoming APIs (Adrenaline, Carbazochrome Sodium Sulphonate, Racepinephrine Hydrochloride) and products under R&D development (Dipivefrine Hydrochloride, Hydralazine Hydrochloride, Isoprenaline Sulphate). All products are manufactured under WHO-GMP and ISO 9001:2015 certified conditions with comprehensive regulatory compliance documentation including DMF/CTD filings.

Differentiator

Problem solved

Functional benefit

Products and services

• Adrenaline API (Adrenaline Bitartrate / Adrenaline Acid Tartrate / Adrenaline Tartrate / Epinephrine Bitartrate)

Quantifiable outcome

• First API developed in India - Carbazochrome JP in 1982
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Piramal Pharma Solutions: Large Indian-headquartered CDMO with broad API development capabilities and global manufacturing footprint. Indirectly competes in similar customer RFPs for complex, niche API supply contracts.
• Aurobindo Pharma: One of India's largest vertically integrated pharmaceutical companies with a substantial API manufacturing arm. Broad incumbent offering APIs plus finished formulations across many more molecules than Medinex.
• Cambrex Corporation: Western specialty API and CDMO player serving global pharma with niche small-molecule APIs. Represents both a competitor and benchmark for Medinex in regulatory quality standards and customer expectations.
• Jubilant Pharmova (Life Sciences): Indian CDMO and API manufacturer with USFDA/EDQM-inspected facilities and a globally diversified customer base. Competes in overlap with Medinex on specialty APIs and contract manufacturing services.

Direct peers

• Divi's Laboratories: India's leading API manufacturer with a comparable niche/specialty API focus, multi-pharmacopoeial compliance, and global regulatory dossier (USFDA, EDQM, etc.). Operates at materially larger scale but competes in overlapping therapeutic API categories.
• Neuland Laboratories: Indian API and contract manufacturer with similar niche-generic API strategy, strong USFDA/EDQM audit history, and CDMO-plus-ingredient business model. Highly comparable in size and regulatory positioning to Medinex.
• Hikal Limited: Indian manufacturer of active pharmaceutical ingredients and intermediates with a focus on custom synthesis and niche molecules. Operates multi-block cGMP facilities similar to Medinex, serves global pharma customers with comparable regulatory filings.
• Solara Active Pharma Sciences: Indian pure-play API manufacturer specializing in niche APIs across therapeutic categories with multi-pharmacopoeial compliance (USP/EP/BP/JP) — closely comparable to Medinex's niche-generic, multi-grade positioning.
• Dishman Carbogen Amcis: Indian API and CRAMS manufacturer with niche, multi-step chemistry expertise and global regulatory approvals. Comparable to Medinex in operating model (complex chemistry, niche APIs) but at larger scale.

Emerging players

• Sequent Scientific (API Division): Indian pharmaceutical company with an API manufacturing segment targeting niche molecules with multi-pharmacopoeial grades. Smaller-scale comparison point and adjacent participant in India's niche-API export ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medinex